[{"data":1,"prerenderedAt":184},["ShallowReactive",2],{"drug-fidaxomicin":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":44,"contraindications":95,"warnings":105,"renal":106,"monitoring":107,"interactions":108,"review":109,"examples":111,"atc":120,"iran":122,"usApproval":129,"links":135,"populations":149},"fidaxomicin",1,{"fa":7,"en":8},"فیداکسومایسین","Fidaxomicin","alimentary-metabolism",{"fa":11,"en":12},"آنتی‌بیوتیک ماکروسیکلیک","Macrocyclic antibiotic",[14],{"name":15,"market":16},"Dificid","US",[18,19,7],"dificid","دیفیسید",[21,35],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"tab-200","tablet","oral","200 mg tablet",{"amount":27,"unit":28,"perUnit":23,"scored":29},200,"mg",false,[16],[32],{"source":33,"section":34},"fda-dificid","3",{"id":36,"form":37,"route":24,"label":38,"concentration":39,"markets":41,"refs":42},"susp-40","suspension","40 mg\u002FmL oral suspension",{"amount":40,"unit":28,"perVolumeMl":5},40,[16],[43],{"source":33,"section":34},[45,64],{"id":46,"disease":47,"label":48,"population":51,"type":55,"unit":28,"dose":56,"refs":58,"durationDays":61,"allowedFormulations":63},"adult","c-diff",{"fa":49,"en":50},"اسهال کلستریدیوئیدس دیفیسیل — بزرگسال ۲۰۰ mg دو بار در روز، ۱۰ روز","C. difficile diarrhoea — adult 200 mg twice daily for 10 days",{"minAge":52},{"value":53,"unit":54},18,"year","fixed",{"perDose":27,"dosesPerDay":57},2,[59],{"source":33,"section":60},"2.2",{"min":62,"max":62},10,[22],{"id":65,"disease":47,"label":66,"population":69,"type":75,"unit":28,"dose":76,"refs":90,"durationDays":93,"allowedFormulations":94},"child",{"fa":67,"en":68},"کودک ۶ ماه تا \u003C۱۸ سال (سوسپانسیون) — ۸۰ \u002F ۱۲۰ \u002F ۱۶۰ \u002F ۲۰۰ mg دو بار در روز بر اساس وزن، ۱۰ روز","Children 6 months–\u003C18 y (suspension) — 80 \u002F 120 \u002F 160 \u002F 200 mg twice daily by weight, 10 days",{"minAge":70,"maxAge":73,"minWeightKg":74},{"value":71,"unit":72},6,"month",{"value":53,"unit":54},4,"weightBand",{"weightBands":77},[78,82,85,88],{"minWeightKg":79,"maxWeightKg":80,"perDose":81,"dosesPerDay":57},3.99,6.99,80,{"minWeightKg":80,"maxWeightKg":83,"perDose":84,"dosesPerDay":57},8.99,120,{"minWeightKg":83,"maxWeightKg":86,"perDose":87,"dosesPerDay":57},12.49,160,{"minWeightKg":86,"maxWeightKg":89,"perDose":27,"dosesPerDay":57},null,[91],{"source":33,"section":92},"2.3, Table 1",{"min":62,"max":62},[36],[96],{"id":97,"severity":98,"text":99,"refs":102},"hyper","block",{"fa":100,"en":101},"حساسیت به فیداکسومایسین.","Hypersensitivity to fidaxomicin.",[103],{"source":33,"section":104},"4",[],[],[],[],{"status":110,"reviewer":89,"date":89},"unverified",[112,117],{"regimen":46,"formulation":22,"input":113,"expect":116},{"ageYears":114,"weightKg":115},60,70,{"perDose":27,"tabletsPerDoseRounded":5},{"regimen":65,"formulation":36,"input":118,"expect":119},{"ageYears":5,"weightKg":62},{"perDose":87,"mlPerDose":74},[121],"A07AA12",{"status":123,"refs":124},"not-found",[125],{"source":126,"section":127,"url":128},"darooyab-generic","search","https:\u002F\u002Fwww.darooyab.ir\u002FSearch?q=Fidaxomicin",{"kind":130,"refs":131,"id":134},"NDA",[132],{"source":33,"section":133},"SPL approval \u002F marketing category","NDA201699",[136,139,143,146],{"kind":137,"url":138,"label":134},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=201699",{"kind":140,"url":141,"label":142},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=dd966338-c820-4270-b704-09ef75fa3ceb","FDA Dificid",{"kind":144,"url":145,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa611040.html",{"kind":147,"url":148,"label":121},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=A07AA12",{"pregnancy":150,"lactation":159,"pediatric":167,"geriatric":175},{"level":151,"text":152,"quote":155,"refs":156},"caution",{"fa":153,"en":154},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary The limited available data on use of DIFICID in pregnant women are insufficient to inform any drug-associated risk for major birth defects, miscarriage or adverse maternal or fetal outcomes.",[157],{"source":33,"section":158},"8.1",{"level":151,"text":160,"quote":163,"refs":164},{"fa":161,"en":162},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Risk Summary There is no information on the presence of fidaxomicin or its main metabolite, OP-1118, in human milk, the effects on the breastfed infant, or the effects on milk production.",[165],{"source":33,"section":166},"8.2",{"level":151,"text":168,"quote":171,"refs":172},{"fa":169,"en":170},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","The safety and effectiveness of DIFICID for the treatment of CDAD have been established in pediatric patients 6 months to less than 18 years of age.",[173],{"source":33,"section":174},"8.4",{"level":176,"text":177,"quote":180,"refs":181},"ok",{"fa":178,"en":179},"برچسب: در سالمندان تفاوت یا تنظیم دوز خاصی ذکر نشده.","Label: no specific difference or dose adjustment stated for older adults.","No dose adjustment is recommended for elderly patients.",[182],{"source":33,"section":183},"8.5",1792191544332]